MTOR and neoplasm: For example, using iopromide as the contrast agent, CEST MRI revealed a statistically significant increase in tumor pHe (~0.10 pH unit) within the first day of the treatment of everolimus (RAD001), an mTOR inhibitor, correlating well with the decreased tumor growth rate.